| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2004 | CN1478470A Nagelinai clathrate compound |
| 03/03/2004 | CN1478469A Capsule possessing antiinflammation, releaving pain and anticancer function and its preparation method |
| 03/03/2004 | CN1478465A Biphenyl diester liquid medicinal composition containing fat |
| 03/03/2004 | CN1140535C Halo derivatives of 9-deoxo-9a-aza-9a-homery theromycin A. |
| 03/03/2004 | CN1140527C Phenyl xanthine ester and amide derivatives |
| 03/03/2004 | CN1140526C 8-azabicyclo[3,2,1] octane-3-methanamine derivatives as ligands of D2 and D3 doppamine and 5HT1A and 5HT2 serotonin receptors |
| 03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 03/03/2004 | CN1140524C 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders |
| 03/03/2004 | CN1140521C Method for preparation of citalopram |
| 03/03/2004 | CN1140520C Tetrahydrofurans |
| 03/03/2004 | CN1140516C Quinoline and quinoxaline compounds which inhibits platelet-derived growth factor on/or p56lck tyrosine kinases |
| 03/03/2004 | CN1140510C Thermodynamically stable from of (R)-3[[(4-fluorophenyl)sulphonyl]amino]- 1,2,3,4-tetraydro-9H-carbazole-9-propanoic acid (ramatroban) |
| 03/03/2004 | CN1140509C Novel vitamin D. analogues |
| 03/03/2004 | CN1140508C Substed 4-biphenyl-4-hydroxybutyric acid derivs, and matrix metalloprotease inhibitors |
| 03/03/2004 | CN1140503C Triazepiones, compound process for their preparation and their therapeutic application |
| 03/03/2004 | CN1140500C Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 03/03/2004 | CN1140498C Novel antiarrhythmic compounds |
| 03/03/2004 | CN1140492C Novel capsaicinoide-like substances having ester bond |
| 03/03/2004 | CN1140297C Stabilized pharmaceutical compositions and stabilizing solvent |
| 03/03/2004 | CN1140289C Gynopathy treating Chinese patent drag with forution of diminishing inflammation and eliminating spot and its prepn. method |
| 03/03/2004 | CN1140285C Compound traditional Chinese oral preparation for treating high blood pressure and preventing cerebral hemorrhage |
| 03/03/2004 | CN1140276C Compound chlorhexidine cream and its preparing method |
| 03/03/2004 | CN1140275C Oral powder for treating mouth disease |
| 03/03/2004 | CN1140272C Antitumor agents |
| 03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 03/03/2004 | CN1140268C Rapamycin formulations for oral administration |
| 03/03/2004 | CN1140267C Compositions for once day treatment of cycloxygenase-2 medicated diseases |
| 03/03/2004 | CN1140266C Use of mixture of diol and alpha-hydrox acid for treatment of hyperkeratotic skin diseases |
| 03/03/2004 | CN1140264C Chewing gum containing colloidal bismuth subcitrate |
| 03/03/2004 | CN1140262C Prepn. of nano hdyroxycamptothecine-dextran grain |
| 03/03/2004 | CN1140261C Use of compositions comprising stabilized biologically effective compounds |
| 03/03/2004 | CN1140182C Coca components, edible products having enhanced polyphenol content, methods of making same and medical us |
| 03/02/2004 | US6700018 3-hydroxy-2-(2-naphthyl)pentylamine derivatives |
| 03/02/2004 | US6700013 O-bromophenylacetic acid derivative chemical intermediate; smooth muscle relaxants, antiinflammatory agents; respiratory system disorders |
| 03/02/2004 | US6699997 Carvedilol |
| 03/02/2004 | US6699996 Production method of isoxazolidinedione compound |
| 03/02/2004 | US6699994 Biaryl compounds as serine protease inhibitors |
| 03/02/2004 | US6699979 Oligonucleotides having chiral phosphorus linkages |
| 03/02/2004 | US6699978 Linker nucleoside, and production and use of the same |
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699912 Producing an aqueous solution of bismuth sodium tartrate; extracting a magma of bismuth sodium tartrate from aqueous solution and dissolving magma into a salting-in mixture to form semitransparent colloidal solution |
| 03/02/2004 | US6699911 Preparation of cyclohexene derivatives intermediates for carotinoids using a mixture of zinc and a salt of ammonium, copper, alkali metal or alkaline earth metal as reducing agent |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699908 Methods for providing safe local anesthesia |
| 03/02/2004 | US6699907 Mastitis prevention in dairy animal; topically applying microbiocide, lipophilic polar solvent comprising propylene glycol, ethylene glycol, glycerol, or isopropanol and fatty acids |
| 03/02/2004 | US6699906 Method of administering lactic acid salts to reduce or prevent exertion-related muscle discomfort |
| 03/02/2004 | US6699905 Comprising administering to the subject an effective anti-inflammatory amount of a pharmaceutical composition comprising a lipoxin a4 compound and a pharmaceutically acceptable carrier |
| 03/02/2004 | US6699904 PPAR agonists |
| 03/02/2004 | US6699903 Hydration of the anhydrous lithium salt with acetonitrile and water; phosphodiesterase inhibitors |
| 03/02/2004 | US6699901 Water solubility, nontoxic, side effect reduction; anticarcinogenic agents |
| 03/02/2004 | US6699900 Antiproliferative agent; oxidation and stress resistance; cardiovascular disorders |
| 03/02/2004 | US6699899 Substituted acylhydroxamic acids and method of reducing TNFα levels |
| 03/02/2004 | US6699895 2-aminothiazoline derivatives and process for preparing the same |
| 03/02/2004 | US6699894 Methods for treatment of inflammatory bowel disease |
| 03/02/2004 | US6699893 Glucocorticoid receptor modulators |
| 03/02/2004 | US6699892 Pharmaceutically acceptable salt of amlodipine and method of preparing the same |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699890 Phosphodiesterase 4 inhibitors |
| 03/02/2004 | US6699889 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 03/02/2004 | US6699888 Antiinflammatory |
| 03/02/2004 | US6699887 Administering a therapeutically effective amount of a pyrrazole sulfide or ether compound to treat the human immunodeficiency virus infection |
| 03/02/2004 | US6699886 Store operated calcium influx inhibitors and methods of use |
| 03/02/2004 | US6699885 Substituted benzimidazole dosage forms and methods of using same |
| 03/02/2004 | US6699883 Antibiotics, bactericides, antitumor |
| 03/02/2004 | US6699882 Paroxetine compositions |
| 03/02/2004 | US6699879 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
| 03/02/2004 | US6699878 Imidazonaphthyridines |
| 03/02/2004 | US6699877 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 03/02/2004 | US6699876 Camptothecin analogue compounds |
| 03/02/2004 | US6699875 Cascade esters of camptothecins and methods of treating cancer using these compounds |
| 03/02/2004 | US6699872 N-substituted urea inhibitors of farnesyl-protein transferase |
| 03/02/2004 | US6699871 Such as 7-((3r)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders |
| 03/02/2004 | US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 03/02/2004 | US6699869 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
| 03/02/2004 | US6699868 Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 03/02/2004 | US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine |
| 03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
| 03/02/2004 | US6699864 Substituted phenyl-piperazine derivatives, their preparation and use |
| 03/02/2004 | US6699863 Regulate, modulate and/or inhibit abnormal cell proliferation. |
| 03/02/2004 | US6699860 Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists |
| 03/02/2004 | US6699859 Treatment of anxiety and convulsions. |
| 03/02/2004 | US6699858 Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 03/02/2004 | US6699857 Tetrahydroquinolinyl 6-methyldihydrothiadiazinone derivatives and use thereof |
| 03/02/2004 | US6699856 Pyrazinones, compositions containing such compounds and methods of use |
| 03/02/2004 | US6699855 Pyrrolopyrazinones useful as serine protease inhibitors |
| 03/02/2004 | US6699854 2-substituted 4-heteroaryl- pyrimidines, inhibitors of cyclin-dependent kinases (cdks) |
| 03/02/2004 | US6699852 Substituted pyridoindoles as serotonin agonists and antagonists |
| 03/02/2004 | US6699851 Amides of polyunsaturated fatty acids with cysteamine-s-phosphate antitumor agents |
| 03/02/2004 | US6699850 Oral formulation of a combination of nitrogen-containing bisphosphonate or its salt and an isoprenoid compound for inhibiting bone resoprtion in a mammal while counteracting the occurrence of adverse gastrointestinal effect |
| 03/02/2004 | US6699847 Antiparasitic formulation |
| 03/02/2004 | US6699846 Such as ischemia and reperfusion injury, using specified glycolipids structurally related to monophosphoryl lipid a but with reduced proinflammatory and pyrogenic activity |
| 03/02/2004 | US6699844 Methods for treating cellular proliferative disorders |
| 03/02/2004 | US6699842 Administering to mammal therapeutically effective amount of dna construct which encodes c-jun deletion mutant inhibitory to tumor promoter-induced ap-1 transcription activity to treat tumor |
| 03/02/2004 | US6699841 Method of preparing physiologically acceptable aqueous solutions, and solutions thus obtained |
| 03/02/2004 | US6699840 Controlled- or delayed-release forms of topiramate |
| 03/02/2004 | US6699835 Formulation of boronic acid compounds |
| 03/02/2004 | US6699832 May contain another compound to treat diabetes, sexual dysfunction, atherosclerosis, insulin resistance, impaired glucose tolerance, hypercholesterolemia or hypertriglyceridemia |
| 03/02/2004 | US6699716 In vivo induction for enhanced function of isolated hepatocytes |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699682 Assay for inhibitors of fatty-acid amide hydrolase |